Registration Strip Icon for monitor Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.

PHAS

PhaseBio Pharmaceuticals (PHAS)

PhaseBio Pharmaceuticals Inc
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:PHAS
DateTimeSourceHeadlineSymbolCompany
05/12/20204:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
05/12/20204:01PMBusiness WirePhaseBio Reports First Quarter 2020 Financial Results and Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
04/24/20205:22PMEdgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/30/20208:30AMEdgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/30/20208:21AMEdgar (US Regulatory)Annual Report (10-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/30/20208:09AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/30/20208:01AMGlobeNewswire Inc.PhaseBio Reports Fourth Quarter and Full-Year 2019 Financial Results and Provides Recent Business HighlightsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/20/20204:13PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
03/04/20204:07PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/26/20204:01PMGlobeNewswire Inc.PhaseBio to Present at Cowen and Company 40th Annual Health Care ConferenceNASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:56PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:55PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:54PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:48PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:43PMEdgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20206:39PMEdgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/14/20201:53PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/13/20204:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/13/20204:01PMGlobeNewswire Inc.PhaseBio Appoints Alex C. Sapir to Board of DirectorsNASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/11/20208:08AMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/11/20208:00AMGlobeNewswire Inc.PhaseBio Announces European Regulatory Update for PB2452NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/04/20204:09PMEdgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
02/04/20204:01PMGlobeNewswire Inc.PhaseBio Announces Case Study Highlighting PB1046 Hemodynamic Data Presented at the 14th Pulmonary Vascular Research Institut...NASDAQ:PHASPhaseBio Pharmaceuticals Inc
01/27/20203:37PMEdgar (US Regulatory)Schedule 13gNASDAQ:PHASPhaseBio Pharmaceuticals Inc
01/17/20201:58PMEdgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NASDAQ:PHASPhaseBio Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PHAS